IL7 and neoplasm: A relative low dose and frequency of IL-7 treatment in our experiments exhibited no effects on the xenograft models of human lung cancer cells, but some studies reported that once the IL-7 treatment was performed daily (5 μg/injection) in cases of lung cancer, the tumor regression was observed to be induced efficiently [26].